Morgan Stanley Initiates Coverage On Sophia Genetics with Overweight Rating, Announces Price Target of $24
Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Overweight rating and announces Price Target of $24.